Delaying progression of arterial disease

Phase 1

• Conditions: Atherosclerosis; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2016-003457-15-IS
• Lead Sponsor: Icelandic Heart Association

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-03-13
• Last Update Posted: 6 November 2017

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 350

Inclusion Criteria

1.Age: 55-70
2.Presence of carotid plaque determined using ultra sound

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 175
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 175

Exclusion Criteria

1.Prevalent heart disease
2.Use of lipid lowering medication
3.Diabetes mellitus (DM)
4.Known peripheral vascular disease
5.Previous strokes
6.Intolerance to rosuvastatin

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified